Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Feb;84(2):154–157. doi: 10.1136/bjo.84.2.154

Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease

M Cahill 1, M Karabatzaki 1, R Meleady 1, H Refsum 1, P Ueland 1, D Shields 1, D Mooney 1, I Graham 1
PMCID: PMC1723379  PMID: 10655190

Abstract

BACKGROUND/AIMS—A moderately elevated plasma concentration of the sulphur amino acid homocysteine is an independent risk factor for atherosclerotic vascular disease. Many of the risk factors associated with coronary, cerebral, and peripheral atherosclerotic vascular disease are common to retinal vascular occlusive disease but it is unclear whether elevated plasma concentrations of homocysteine are also associated with such disease. This study assessed the relation between retinal vascular occlusive disease and elevated levels of plasma total homocysteine (tHcy).
METHODS—A retrospective case-control study involving hospital based controls and cases with retinal artery, central retinal vein (including hemiretinal vein), and branch retinal vein occlusions was performed. The relation between elevated tHcy, defined as a level greater than or equal to 12 µmol/l and risk of retinal vascular occlusive disease was examined.
RESULTS—87 cases of retinal vascular occlusive disease including 26 cases of retinal artery occlusion, 40 cases with central retinal vein occlusion, and 21 cases of branch retinal vein occlusion were compared with 87 age matched controls. Mean tHcy levels were higher in all disease groups and this difference was significant in patients with retinal artery occlusions (p= 0.032) and patients with central retinal vein occlusion (p=0.0001). When adjusted for known cardiovascular risk factors, tHcy was an independent risk factor for retinal vascular occlusive disease (OR 2.85 (95% CI 1.43-5.68)).
CONCLUSIONS—Elevated tHcy is an independent risk factor for retinal vascular occlusive disease. Assessment of tHcy may be important in the investigation and management of patients with retinal vascular occlusive disease.



Full Text

The Full Text of this article is available as a PDF (116.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biousse V., Newman N. J., Sternberg P., Jr Retinal vein occlusion and transient monocular visual loss associated with hyperhomocystinemia. Am J Ophthalmol. 1997 Aug;124(2):257–260. doi: 10.1016/s0002-9394(14)70800-1. [DOI] [PubMed] [Google Scholar]
  2. Boushey C. J., Beresford S. A., Omenn G. S., Motulsky A. G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA. 1995 Oct 4;274(13):1049–1057. doi: 10.1001/jama.1995.03530130055028. [DOI] [PubMed] [Google Scholar]
  3. CARSON N. A., NEILL D. W. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland. Arch Dis Child. 1962 Oct;37:505–513. doi: 10.1136/adc.37.195.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clarke R., Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. J Cardiovasc Risk. 1998 Aug;5(4):249–255. [PubMed] [Google Scholar]
  5. Dhôte R., Bachmeyer C., Horellou M. H., Toulon P., Christoforov B. Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol. 1995 Sep;120(3):388–389. doi: 10.1016/s0002-9394(14)72170-1. [DOI] [PubMed] [Google Scholar]
  6. Fiskerstrand T., Refsum H., Kvalheim G., Ueland P. M. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem. 1993 Feb;39(2):263–271. [PubMed] [Google Scholar]
  7. Graham I. M., Daly L. E., Refsum H. M., Robinson K., Brattström L. E., Ueland P. M., Palma-Reis R. J., Boers G. H., Sheahan R. G., Israelsson B. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997 Jun 11;277(22):1775–1781. doi: 10.1001/jama.1997.03540460039030. [DOI] [PubMed] [Google Scholar]
  8. Greven C. M., Slusher M. M., Weaver R. G. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995 Dec;120(6):776–783. doi: 10.1016/s0002-9394(14)72731-x. [DOI] [PubMed] [Google Scholar]
  9. Hollenhorst R. W. Vascular status of patients who have cholesterol emboli in the retina. Am J Ophthalmol. 1966 May;61(5 Pt 2):1159–1165. doi: 10.1016/0002-9394(66)90238-8. [DOI] [PubMed] [Google Scholar]
  10. Larsson J., Olafsdottir E., Bauer B. Activated protein C resistance in young adults with central retinal vein occlusion. Br J Ophthalmol. 1996 Mar;80(3):200–202. doi: 10.1136/bjo.80.3.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mandel H., Brenner B., Berant M., Rosenberg N., Lanir N., Jakobs C., Fowler B., Seligsohn U. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis. N Engl J Med. 1996 Mar 21;334(12):763–768. doi: 10.1056/NEJM199603213341204. [DOI] [PubMed] [Google Scholar]
  12. Mangat H. S. Retinal artery occlusion. Surv Ophthalmol. 1995 Sep-Oct;40(2):145–156. doi: 10.1016/s0039-6257(95)80004-2. [DOI] [PubMed] [Google Scholar]
  13. Mitchell P., Smith W., Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol. 1996 Oct;114(10):1243–1247. doi: 10.1001/archopht.1996.01100140443012. [DOI] [PubMed] [Google Scholar]
  14. Peduzzi M., Debbia A., Guerrieri F., Bolzani R. Abnormal blood rheology in retinal vein occlusion. A preliminary report. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):83–85. doi: 10.1007/BF02144143. [DOI] [PubMed] [Google Scholar]
  15. Russell R. W. The source of retinal emboli. Lancet. 1968 Oct 12;2(7572):789–792. doi: 10.1016/s0140-6736(68)92453-7. [DOI] [PubMed] [Google Scholar]
  16. Selhub J., Jacques P. F., Wilson P. W., Rush D., Rosenberg I. H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993 Dec 8;270(22):2693–2698. doi: 10.1001/jama.1993.03510220049033. [DOI] [PubMed] [Google Scholar]
  17. Trope G. E., Lowe G. D., McArdle B. M., Douglas J. T., Forbes C. D., Prentice C. M., Foulds W. S. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol. 1983 Mar;67(3):137–142. doi: 10.1136/bjo.67.3.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Welch G. N., Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998 Apr 9;338(15):1042–1050. doi: 10.1056/NEJM199804093381507. [DOI] [PubMed] [Google Scholar]
  19. Wenzler E. M., Rademakers A. J., Boers G. H., Cruysberg J. R., Webers C. A., Deutman A. F. Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol. 1993 Feb 15;115(2):162–167. doi: 10.1016/s0002-9394(14)73919-4. [DOI] [PubMed] [Google Scholar]
  20. Williamson T. H. Central retinal vein occlusion: what's the story? Br J Ophthalmol. 1997 Aug;81(8):698–704. doi: 10.1136/bjo.81.8.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Williamson T. H., Lowe G. D., Baxter G. M. Influence of age, systemic blood pressure, smoking, and blood viscosity on orbital blood velocities. Br J Ophthalmol. 1995 Jan;79(1):17–22. doi: 10.1136/bjo.79.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Williamson T. H., Rumley A., Lowe G. D. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol. 1996 Mar;80(3):203–208. doi: 10.1136/bjo.80.3.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. den Heijer M., Koster T., Blom H. J., Bos G. M., Briet E., Reitsma P. H., Vandenbroucke J. P., Rosendaal F. R. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996 Mar 21;334(12):759–762. doi: 10.1056/NEJM199603213341203. [DOI] [PubMed] [Google Scholar]
  24. den Heijer M., Rosendaal F. R., Blom H. J., Gerrits W. B., Bos G. M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost. 1998 Dec;80(6):874–877. [PubMed] [Google Scholar]
  25. vd Berg W., Verbraak F. D., Bos P. J. Homocystinuria presenting as central retinal artery occlusion and longstanding thromboembolic disease. Br J Ophthalmol. 1990 Nov;74(11):696–697. doi: 10.1136/bjo.74.11.696. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES